Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) today announced that it has priced its previously announced underwritten public offering of 5,000,000 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE